Download PDF
Thromb Haemost 1988; 59(02): 277-280
DOI: 10.1055/s-0038-1642770
Original Articles
Schattauer GmbH Stuttgart

Congenital Deficiency of Plasminogen and Its Relationship to Venous Thrombosis

V Hach-Wunderle
1   The Department of Internal Medicine, University Hospital, Frankfurt/Main, FRG
,
I Scharrer
1   The Department of Internal Medicine, University Hospital, Frankfurt/Main, FRG
,
R Lottenberg
2   The Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA
› Author Affiliations
Further Information

Publication History

Received 16 June 1987

Accepted after revision 21 December 1987

Publication Date:
21 May 2018 (online)

  PDF Download  Permissions and Reprints

Summary

In a patient with deep venous thrombosis, plasma concentrations of coagulant and inhibitor proteins were normal except for moderate deficiency of plasminogen. Family studies revealed a similar deficiency in the mother and sister of the propositus. Evaluation of purified plasminogen demonstrated that it functioned normally. The patient represents our only example of plasminogen deficiency in 435 German individuals evaluated with a history of thromboembolism.

Keywords

Deep vein thrombosis - Deficiency of plasminogen - Hypercoagulability - Hypoplasminogenemia
 

  • References

  • 1 Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965; 13: 516-530
    PubMedGoogle Scholar
  • 2 Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373
    CrossrefPubMedGoogle Scholar
  • 3 Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984; 74: 2082-2088
    CrossrefPubMedGoogle Scholar
  • 4 Isacson S, Nilsson IM. Defective fibrinolysis in blood in vein walls in recurrent idiopathic venous thrombosis. Acta Chir Scand 1972; 138: 313-319
    PubMedGoogle Scholar
  • 5 Wiman B, Ljundberg B, Chmielewska J, Urden G, Blomback M, Johnsson H. The role of the fibrinolytic system in deep vein thrombosis. J Lab Clin Med 1985; 105: 265-270
    PubMedGoogle Scholar
  • 6 Sas G, Blasko G, Banhegyi D, Jako J, Palos LA. Abnormal antithrombin III (Antithrombin Budapest) as a cause of familial thrombophilia. Thromb Diath Haemorrh 1974; 32: 105-115
    PubMedGoogle Scholar
  • 7 Rodgers GM, Shuman MA. Congenital thrombotic disorders. Amer J Hematol 1986; 21: 419-430
    CrossrefPubMedGoogle Scholar
  • 8 Griffin JH, Bezeaud A, Evatt B, Mosher D. Functional and immunological studies of protein S in thromboembolic disease. Blood 1983; 62: 301-301 Abstr
    PubMedGoogle Scholar
  • 9 Aoki N, Moroi M, Sakata Y, Yoshida N, Matsuda M. Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis. J Clin Invest 1978; 61: 1186-1195
    CrossrefPubMedGoogle Scholar
  • 10 Wohl RC, Summaria L, Robbins KC. Physiological activation of the human fibrinolytic system. Isolation and characterization of human plasminogen variants, Chicago I and Chicago II. J Biol Chem 1979; 254: 9063-9069
    PubMedGoogle Scholar
  • 11 Wohl RC, Summaria L, Chediak J, Rosenfeld S, Robbins KC. Human plasminogen variant Chicago III. Thromb Haemostas 1982; 48: 146-152
    PubMedGoogle Scholar
  • 12 Miyata T, Iwanaga S, Sakata Y, Aoki N. Plasminogen Tochigi: Inactive plasmin from replacement of alanine-600 by threonine in the active site. Proc Natl Acad Scie USA 1982; 79: 6132-6136
    CrossrefPubMedGoogle Scholar
  • 13 Miyata T, Iwanaga S, Sakata Y, Aoki N, Takamatsu J, Kamiya T. Plasminogens Tochigi II and Nagoya. Two additional molecular defects with Ala-600-Thr replacement found in plasmin light chain variants. J Biochem 1984; 96: 277-287
    CrossrefPubMedGoogle Scholar
  • 14 Kazama M, Tahara C, Suzuki Z, Gohchi K, Abe T. Abnormal plasminogen, a case of recurrent thrombosis. Thromb Res 1981; 21: 517-22
    CrossrefPubMedGoogle Scholar
  • 15 Soria J, Soria C, Bertrand O, Dunn F, Drouet L, Caen JP. Plasminogen Paris I: Congenital abnormal plasminogen and its incidence to thrombosis. Thromb Res 1983; 32: 229-238
    CrossrefPubMedGoogle Scholar
  • 16 Sakata Y, Aoki N. Molecular abnormality of plasminogen. J Biol Chem 1980; 225: 5442-5447
    PubMedGoogle Scholar
  • 17 Aoki N, Tateno K, Sakata Y. Differences of frequency distribution of plasminogen phenotypes between Japanese and American populations: New methods for the detection of plasminogen variants. Biochem Genet 1984; 22: 871-881
    CrossrefPubMedGoogle Scholar
  • 18 Scharrer IM, Wohl RC, Hach V, Sinio L, Boreisha I, Robbins KC. Investigation of a congenital abnormal plasminogen, Frankfurt I, and its relationship to thrombosis. Thromb Haemostas 1986; 55: 396-401
    PubMedGoogle Scholar
  • 19 Hasegawa DK, Tyler BJ, Edson JR. Thrombotic disease in 3 families with inherited plasminogen deficiency. Blood Suppl (Suppl. 01) 1982; 60: 213a-213a Abstr
    PubMedGoogle Scholar
  • 20 Ten Cate JW, Peters M, Biiller H. Isolated plasminogen deficiency in a patient with recurrent thromboembolic complications. Thromb Haemostas 1983; 50: 59-59 Abstr
    PubMedGoogle Scholar
  • 21 Lottenberg R, Dolly FR, Kitchens CS. Recurring thromboembolic disease and pulmonary hypertension associated with severe hypoplas- minogenemia. Amer J Hematol 1985; 19: 181-193
    CrossrefPubMedGoogle Scholar
  • 22 Mannucci PM, Kluft C, Traas DW, Seveso P, D’Angelo A. Congenital plasminogen deficiency associated with venous thromboembolism: therapeutic trial with stanazol. Br J Haem 1986; 63: 753-759
    CrossrefPubMedGoogle Scholar
  • 23 Laurell CB. Quantitative estimation of protein by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-45
    CrossrefPubMedGoogle Scholar
  • 24 Friberger P, Knos M, Gustavsson S, Aurell L, Claeson G. Methods for determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251. Haemostasis 1978; 7: 138-145
    PubMedGoogle Scholar
  • 25 Lijnen HR, von Hoef B, Collen D. On the role of the carbohydrate side chains of human plasminogen in its interaction with alpha2-antiplasmin and fibrin. Eur J Biochem 1981; 120: 149-154
    CrossrefPubMedGoogle Scholar
  • 26 Peltz SW, Hardt TA, Mangel WF. Positive regulation of activation of plasminogen by urokinase: differences in Km for (glutamic acid)-plasminogen and lysine-plasminogen and effect of certain ω-aminoacids. Biochemistry 1982; 21: 2798-2804
    CrossrefPubMedGoogle Scholar
  • 27 Gram J, Jespersen J. A functional plasminogen assay utilizing the potentiating effect of fibrinogen to correct for the overestimation of plasminogen in pathological plasma samples. Thromb Haemostas 1985; 53: 255-259
    PubMedGoogle Scholar